Alliancebernstein L.P. Poly Pid Ltd. Transaction History

Alliancebernstein L.P.

  • $287 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
BUY
$4.35 - $5.76 $65,219 - $86,359
14,993 Added 14.99%
114,993 $534,000
Q2 2020

Aug 13, 2020
BUY
$18.03 - $19.0 $1.8 Million - $1.9 Million
100,000 New
100,000 $1.8 Million

About PolyPid Ltd.

PYPD Quotes by TradingView
  • Ticker PYPD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 19,551,200
  • Market Cap $64.5M
  • Description
  • PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product candidate is D-PLEX100, which is in Phase III clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well a...
More about PYPD
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email